Oncopeptides AB (publ) ONCO.ST Stock
4.96 SEK
{{ price }}
-1.391653%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
448.58M SEK
LOW - HIGH [24H]
4.83
-
5.2 SEK
VOLUME [24H]
444.59K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-2.87 SEK
Oncopeptides AB (publ) Price Chart
Oncopeptides AB (publ) ONCO.ST Financial and Trading Overview
| Oncopeptides AB (publ) stock price | 4.96 SEK |
| Previous Close | 8.25 SEK |
| Open | 8.25 SEK |
| Bid | 8.27 SEK x 0 |
| Ask | 8.27 SEK x 0 |
| Day's Range | 8.1 - 8.32 SEK |
| 52 Week Range | 7.7 - 50.84 SEK |
| Volume | 278.7K SEK |
| Avg. Volume | 403.99K SEK |
| Market Cap | 745.36M SEK |
| Beta (5Y Monthly) | -0.605747 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.87 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.33 SEK |
ONCO.ST Valuation Measures
| Enterprise Value | 530.56M SEK |
| Trailing P/E | N/A |
| Forward P/E | -2.805442 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 78.63288 |
| Price/Book (mrq) | 3.40545 |
| Enterprise Value/Revenue | 55.972 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Oncopeptides AB (publ) Stock Price History
| Beta (5Y Monthly) | -0.605747 |
| 52-Week Change | -23.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 50.84 SEK |
| 52 Week Low | 7.7 SEK |
| 50-Day Moving Average | 9.54 SEK |
| 200-Day Moving Average | 13.2 SEK |
ONCO.ST Share Statistics
| Avg. Volume (3 month) | 403.99K SEK |
| Avg. Daily Volume (10-Days) | 380.5K SEK |
| Shares Outstanding | 90.37M |
| Float | 59.28M |
| Short Ratio | N/A |
| % Held by Insiders | 10.01% |
| % Held by Institutions | 46.49% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3409.90% |
| Gross Margin | 99.82% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.90% |
| Return on Equity (ttm) | -178.61% |
Income Statement
| Revenue (ttm) | 9.48M SEK |
| Revenue Per Share (ttm) | 0.11 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 8.35M SEK |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -310388992 SEK |
| Diluted EPS (ttm) | -3.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 251.9M SEK |
| Total Cash Per Share (mrq) | 2.67 SEK |
| Total Debt (mrq) | 4.41M SEK |
| Total Debt/Equity (mrq) | 1.93 SEK |
| Current Ratio (mrq) | 3.532 |
| Book Value Per Share (mrq) | 2.422 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -343472992 SEK |
| Levered Free Cash Flow (ttm) | -230872496 SEK |
Profile of Oncopeptides AB (publ)
| Country | Sweden |
| State | N/A |
| City | Stockholm |
| Address | Vastra Tradgardsgatan 15 |
| ZIP | 111 53 |
| Phone | 46 86 15 20 40 |
| Website | https://www.oncopeptides.com/sv |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 59 |
Oncopeptides AB (publ), a biotech company, engages in the commercialization, and research and development of treatments for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is melflufen, a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden
Q&A For Oncopeptides AB (publ) Stock
What is a current ONCO.ST stock price?
Oncopeptides AB (publ) ONCO.ST stock price today per share is 4.96 SEK.
How to purchase Oncopeptides AB (publ) stock?
You can buy ONCO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oncopeptides AB (publ)?
The stock symbol or ticker of Oncopeptides AB (publ) is ONCO.ST.
Which industry does the Oncopeptides AB (publ) company belong to?
The Oncopeptides AB (publ) industry is Biotechnology.
How many shares does Oncopeptides AB (publ) have in circulation?
The max supply of Oncopeptides AB (publ) shares is 90.44M.
What is Oncopeptides AB (publ) Price to Earnings Ratio (PE Ratio)?
Oncopeptides AB (publ) PE Ratio is now.
What was Oncopeptides AB (publ) earnings per share over the trailing 12 months (TTM)?
Oncopeptides AB (publ) EPS is -2.87 SEK over the trailing 12 months.
Which sector does the Oncopeptides AB (publ) company belong to?
The Oncopeptides AB (publ) sector is Healthcare.
Oncopeptides AB (publ) ONCO.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5132.25 SEK 500.97 USD |
+0.49
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Small_Cap_PI OMXSSCPI | 1196.96 SEK 116.84 USD |
-0.26
|
— — | — — | — — | — - | — — |
| OMX Stockholm_PI OMXSPI | 947.32 SEK 92.47 USD |
-0.04
|
— — | — — | — — | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 456.92 SEK 44.6 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 517.93 ISK 3.81 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 349.16 DKK 51.19 USD |
-0.69
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2564.43 SEK 250.32 USD |
-0.59
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4204.43 SEK 410.4 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 6954.45 SEK 678.84 USD |
+0.49
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 596.42 SEK 58.22 USD |
-0.19
|
— — | — — | — — | — - | — — |
| OMX Stockholm_GI OMXSGI | 466.5 SEK 45.54 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 435.1 SEK 42.47 USD |
-0.21
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 349.01 EUR 381.52 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}